Cardiac arrest with pulseless electrical activity associated with methylphenidate in an adolescent with a normal baseline echocardiogram

Pharmacotherapy

Volumn 28, Issue 11 PART 1, 2008, Pages 1408-1412

  Daly, Michael W ^a,b   Custer, Geoffrey ^a   McLeay, Peter D ^c  

^a ST LUKE S HOSPITAL   (United States)

^b ST LOUIS COLLEGE OF PHARMACY   (United States)

^c Heartland Cardiology   (United States)

Author keywords

ADHD; Attention deficit hyperactivity disorder; Cardiac arrest; Methylphenidate; Pulseless electrical activity

Indexed keywords

ADRENALIN; AMIODARONE; CALCIUM CHLORIDE; CREATINE KINASE; GLYCERYL TRINITRATE; MAGNESIUM; METHYLPHENIDATE; METOPROLOL; METOPROLOL TARTRATE; MYOGLOBIN; NICARDIPINE; TROPONIN T;

ADOLESCENT; ANGIOCARDIOGRAPHY; ARTICLE; ARTIFICIAL VENTILATION; ATTENTION DEFICIT DISORDER; BLOOD CHEMISTRY; BLOOD PRESSURE MEASUREMENT; BRAIN DISEASE; BRAIN HYPOXIA; BURNING SENSATION; CASE REPORT; COMA; CORONARY ARTERY SPASM; DEFIBRILLATION; DRUG DOSE TITRATION; ECHOCARDIOGRAPHY; ELECTRIC ACTIVITY; HEART ARREST; HEART CATHETERIZATION; HEART MURMUR; HEART RATE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPOKINESIA; MALE; MASS FRAGMENTOGRAPHY; MENTAL DEFICIENCY; PHYSICAL EXAMINATION; PROBABILITY; RESUSCITATION; SHUNTING; SINUS TACHYCARDIA; THORAX PAIN;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CARDIOPULMONARY RESUSCITATION; CENTRAL NERVOUS SYSTEM STIMULANTS; COMA; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; HEART ARREST; HUMANS; HYPOXIA, BRAIN; MALE; METHYLPHENIDATE; VENTRICULAR FIBRILLATION;

EID: 55549124194     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.11.1408     Document Type: Article

References (13)

1. Nissen SE. ADHD drugs and cardiovascular risk. N Engl J Med 2006;354:1445-8.
2. Knight M. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death. Pediatrics 2007;119:154-5.
3. Vetter VL, Elia J, Erickson C, et al. Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder: a scientific statement from the American Heart Association council on cardiovascular disease in the young congenital cardiac defects committee and council on cardiovascular nursing. Circulation 2008;117:2407-23.
4. U.S. Food and Drug Administration. Drug safety and risk management advisory committee meeting, February 9-10, 2006. Available from http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4202_00_TOC.htm. Accessed February 20, 2007.
5. U.S. Food and Drug Administration, Office of Drug Safety. Follow-up review of AERS search identifying cases of sudden death occurring with drugs used for the treatment of attention deficit hyperactivity disorder (ADHD), 2006. Available from www.fda.gov/ohrms/dockets/ac/06/briefing/2006- 4210b_07_01_safetyreview.pdf. Accessed February 20 2007.
6. Hammerness PG, Wilens TE, Berul CI, Elkort MS. Supraventricular tachycardia in an adolescent with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Pyschiatry 2008;47:219-20.
7. Gandhi PJ, Ezeala GU, Luyen TT, Tu TC, Tran MT. Myocardial infarction in an adolescent taking Adderall. Am J Health-Syst Pharm 2005;62:1494-7.
8. Lucas PB, Gardner DL, Wolkowitz OM, Tucker EE, Cowdry RW. Methylphenidate-induced cardiac arrhythmias [case report]. N Engl J Med 1986;315:1485.
9. Fischer VW, Barner H. Cardiomyopathic findings associated with methylphenidate [case report]. JAMA 1977;238:1497.
10. Wilens TE, Prince JB, Spencer TJ, et al. Stimulants and sudden death: what is a physician to do? Pediatrics 2006;118:1215-19.
11. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
12. Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions: current perspectives and future needs. JAMA 1999;281:824-9.
13. Bennett CL, Nebeker JR, Lyons EA, et al. The research on adverse drug events and reports (RADAR) project. JAMA 2005;293:2131-40.